Trimi vs MEDVi

Both sell tirzepatide. Trimi costs $125 a month and MEDVi costs $399, a difference of $274 a month or about $3,288 a year. The desk reads it as follows.

Trimi is lowest flat price with named pharmacies. MEDVi is tablet and injection choice. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.

Advert against bill. Trimi advertises $125 and bills $125; MEDVi advertises $399 and bills $399. Both gaps are the same size, so the advertised comparison happens to hold.

Side by side

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The split

They differ on 4 of the 7 things we track, and behave the same on the other 3. The differences are what the price gap is actually buying.

What each puts on the record: Trimi

• Compounded tirzepatide advertised at $125/month on the annual plan.
• Compounded semaglutide advertised at $99/month on the annual plan.
• Price is the same at every prescribed dose.
• One flat charge covers medication, clinician visits, check-ins and free overnight shipping; no separate membership.
• Names its compounding pharmacies publicly: VialsRx (Texas Board of Pharmacy #35264) and GreenwichRx, with a certificate of analysis available on request.
• Medical oversight via Arora Health, a 50-state network led by Dr. Sean Arora, MD.
• Advertises a six-month money-back promise subject to terms.

Where it wins: The cheapest verified flat rate for compounded tirzepatide in this comparison. Watch for: Both headline prices are annual-plan rates. Confirm the month-to-month figure and the refund terms before prepaying twelve months.

What each puts on the record: MEDVi

• Compounded tirzepatide injections listed at $399/month.
• Tirzepatide tablet pricing is quoted after the intake questionnaire rather than published up front.

Where it wins: Injection pricing is consistent between the first month and renewals. Watch for: You have to complete intake before seeing tablet pricing. Injection pricing is published at $399.

In each one’s favour

Trimi.

• The cheapest verified flat rate for compounded tirzepatide in this comparison.
• Names its pharmacies with a licence number and offers a certificate of analysis — almost nobody else in this market does.

MEDVi.

• Injection pricing is consistent between the first month and renewals.
• Tablet option for people who will not inject.

How they score

Trimi scores higher overall at 4.6 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

The desk’s call

• Pick Trimi if cost is the binding constraint. Over a year the gap is about $3,288, which is real money for the same class of medication.
• Pick MEDVi if what it does better matters to you — injection pricing is consistent between the first month and renewals.
• If sourcing matters, note that Trimi publishes which pharmacy compounds its medication and MEDVi does not.

The verdict

On the board, Trimi at $125 a month is the more defensible choice on arithmetic alone. MEDVi earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Trimi and MEDVi.

How they sit against everyone else